|
|
|
|
| LEADER |
00000nam a2200000 a 4500 |
| 001 |
ccb6c220-2932-49c2-be61-ce2d56be02d2 |
| 005 |
20240705000000.0 |
| 008 |
091013s2009 maua b 100 0 eng |
| 015 |
|
|
|a GBA9C4024
|2 bnb
|
| 016 |
7 |
|
|a 101521192
|2 DNLM
|
| 016 |
7 |
|
|a 015440737
|2 Uk
|
| 019 |
|
|
|a 455200107
|
| 020 |
|
|
|a 9781573317597
|
| 020 |
|
|
|a 1573317594
|
| 035 |
|
|
|a (OCoLC)456260916
|
| 040 |
|
|
|a NLM
|c NLM
|d ORE
|d CUX
|d UMS
|d RRR
|d UKM
|d AGL
|d CHVBK
|d YDXCP
|d MnU-B
|
| 042 |
|
|
|a nlmcopyc
|
| 060 |
0 |
0 |
|a W1
|b AN626YL v.1174 2009
|
| 060 |
1 |
0 |
|a QZ 266
|b I6082c 2009
|
| 070 |
0 |
|
|a RC271.I45
|b I583 2008
|
| 082 |
0 |
4 |
|a 616.994061
|2 22
|
| 090 |
|
|
|a Q11
|b .N4 v.1174
|
| 111 |
2 |
|
|a International Cancer Vaccine Symposium
|n (6th :
|d 2008 :
|c New York, N.Y.)
|
| 245 |
1 |
0 |
|a Cancer vaccines :
|b sixth international symposium /
|c edited by Ralph Steinman, Jacques Banchereau, and Olivera J. Finn.
|
| 246 |
3 |
0 |
|a Cancer vaccines :
|b 6th international symposium
|
| 246 |
1 |
|
|i Conference title:
|a Stages of cancer vaccine development
|
| 260 |
|
|
|a Boston, MA :
|b Published by Blackwell Pub. on behalf of the New York Academy of Sciences,
|c 2009.
|
| 300 |
|
|
|a vi, 121 pages :
|b illustrations ;
|c 26 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|
| 490 |
1 |
|
|a Annals of the New York Academy of Sciences,
|x 0077-8923 ;
|v v. 1174
|
| 500 |
|
|
|a "This volume presents manuscripts stemming from the conference "Sixth International Cancer Vaccine Symposium: Stages of Cancer Vaccine Development," held at the New York Academy of Sciences Conference Center on Oct. 28-30, 2008."--P. v.
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 505 |
0 |
|
|a Some scientific and organizational challenges in cancer immunology / Ralph M. Steinman -- The human cancer antigen mesothelin is more efficiently presented to the mouse immune system when targeted tothe DEC-205/CD205 receptor on dendritic cells / Bei Wang ... [et al.] -- Brain tumor immunotherapy with type-1 polarizing strategies / Hideho Okada -- Harnessing human dendritic cell subsets to design novel vaccines / Jacques Banchereau ... [et al.] -- Dendritic cell-based vaccines for pancreatic cancer and melanoma / James J. Mulé -- Combining conventional therapies with intratumoral injection of autologous dendritic cells and activated t cells tp treat patients with advanced cancers / Dean L. Mann ... [et al.] -- Witch hunt against tumor cells enhanced by dendritic cells / Clara Locher ... [et al.] -- Harnessing CD1d-restricted t cells toward antitumor immunity in humans / Natalia Neparidze and Madhav V. Dhodapkar -- Immunity against cyclin B1 tumor antigen delays development of spontaneous cyclin B1-positive tumors in p53 -/- mice / Laura A. Vella ... [et al.] -- Targets of protective tumor immunity / Glenn dranoff --
|
| 505 |
0 |
|
|a Identification of immunologic biomarkers associated with clinical response after immune-based therapy for cancer / Yushe Dang and Mary L. Disis -- harnessing dendritic cells to generate cancer vaccines / Karolina Palucka ... [et al.] -- Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory t cells / Andrew J. Rech and Robert H. Vonderheide -- Strategies to enhance the therapeutic activity of cancer vaccines: using melanoma as a model / Neil L. Berinstein -- Hematopoietic stem and progenitor cells and the inflammatory response / Siddhartha Jaiswal and Irving L. Weissman.
|
| 650 |
|
0 |
|a Cancer vaccines
|v Congresses.
|
| 650 |
1 |
2 |
|a Cancer Vaccines
|
| 655 |
|
2 |
|a Congress
|
| 700 |
1 |
|
|a Steinman, Ralph M.
|
| 700 |
1 |
|
|a Banchereau, Jacques.
|
| 700 |
1 |
|
|a Finn, Olivera J.
|
| 773 |
1 |
8 |
|g no:1174-1175
|w 9939180800001701
|
| 830 |
|
0 |
|a Annals of the New York Academy of Sciences
|v v. 1174.
|
| 999 |
1 |
0 |
|i ccb6c220-2932-49c2-be61-ce2d56be02d2
|l 9946588720001701
|s US-MNU
|m cancer_vaccinessixth_international_symposium_______________________________2009_______publia________________________________________international_cancer_______________p
|